151. IL-27 Inhibits Hyperglycemia and Pancreatic Islet Inflammation Induced by Streptozotocin in Mice
- Author
-
Yoshiyuki Miyazaki, Hirokazu Fujimoto, Hiroki Yoshida, Hiromitsu Hara, Koichi Node, Ai Nishimoto-Hazuku, Christiaan J. M. Saris, Noriko Ide-Iwata, and Tetsuaki Hirase
- Subjects
Blood Glucose ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Neutrophils ,medicine.medical_treatment ,Gene Expression ,Inflammation ,Biology ,Transfection ,Streptozocin ,Pathology and Forensic Medicine ,Islets of Langerhans ,Mice ,Internal medicine ,Cytokine Receptor gp130 ,medicine ,Animals ,Hypoglycemic Agents ,Proinsulin ,geography ,Antibiotics, Antineoplastic ,geography.geographical_feature_category ,Interleukin-17 ,Regular Article ,EBI3 ,Receptors, Interleukin ,Islet ,Streptozotocin ,Recombinant Proteins ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Cytokine ,Endocrinology ,Pancreatitis ,Hyperglycemia ,Interleukin 17 ,medicine.symptom ,Pancreas ,Immunosuppressive Agents ,Signal Transduction ,medicine.drug - Abstract
Inflammation driven by immune cells and pro-inflammatory cytokines is implicated in pancreatic β-cell injury, leading to the development of diabetes mellitus. IL-27, a cytokine consisting of IL-27p28 and Epstein-Barr virus-induced gene 3 (EBI3), binds a membrane-bound heterodimeric receptor consisting of the IL-27 receptor α chain (WSX-1) and gp130. IL-27 has anti-inflammatory properties that regulate T-cell polarization and cytokine production. We evaluated blood glucose and islet proinsulin concentrations, inflammatory cell infiltration in islets, and expression of IL-1β mRNA in pancreas in wild-type (WT), EBI3(-/-), and WSX-1(-/-) mice treated with streptozotocin (STZ). Hyperglycemia was augmented in EBI3(-/-) and WSX-1(-/-) mice compared with WT mice. Islet proinsulin levels after STZ treatment were lower in EBI3(-/-) and WSX-1(-/-) mice than in WT mice. The infiltration of islets by F4/80(+)CD11c(-)7/4(-) macrophages, CD4(+) T cells, and CD8(+) T cells was increased in EBI3(-/-) and WSX-1(-/-) mice compared with WT mice. The administration of recombinant IL-27, compared with control, decreased the blood glucose level, immune cell infiltration into islets, and IL-1β mRNA expression in the pancreas and increased islet proinsulin levels in WT and EBI3(-/-) mice. Thus, IL-27 inhibits STZ-induced hyperglycemia and pancreatic islet inflammation in mice and represents a potential novel therapeutic approach for β-cell protection in diabetes.
- Published
- 2011
- Full Text
- View/download PDF